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1 Introduction to the work 
 
1.1 Presentation of the topic 
Healthcare was for long not considered a matter to be dealt with by the European Union 
(EU). It was looked at as outside of the competence of the EU and the legal entitlements 
of the individual patient to access healthcare services, both inside and outside of its 
country of residence, was considered purely a matter of national law.  
Healthcare services and systems are organized and financed differently between the EU 
Member States. Broadly, the systems can be classified as social insurance based 
Bismarck systems (with a further distinction between benefits in kind and restitution 
systems) and publicly funded Beveridge systems (also known as national health 
services funded centrally by taxation).1 The various legal systems of the Member States 
have different rules on how expenses for healthcare obtained abroad are reimbursed and 
the EU has not been involved in regulating these payments.  
The right to get healthcare in another EU Member State, and have the expenses covered 
by the home State, was first established by Regulation 1408/71 on the application of 
social security schemes to employed persons and their families moving within the 
Community (later replaced by Regulation 883/2004 on the coordination of social 
security systems). The Regulation was intended to guarantee workers and their family 
members the right to social security benefits regardless of their country of employment. 
This made it possible for people to use their right to free movement within the Union. 
Coordination of the various social security systems was therefore the main goal of the 
Regulation, as well as giving individuals certain restricted rights to reimbursement of 
foreign medical expenses.   
                                                 
1
 Health Systems Governance in Europe: The Role of European Union Law and Policy, Elias Mossialos 
... [et al.]. Cambridge, (Cambridge University Press) 2010, p.12. For further reading about the different 
systems: Bismarck versus Beveridge: Social Insurance Systems in Europe, Center for Economic Studies 
Institute, report 4/2008. http://www.cesifo-group.de – last visited 15 November 2011 
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Today the situation is, however, very much different. The European Court of Justice 
(“Court of Justice” or “Court”) gave, in its famous rulings in the cases of Kohll2 and 
Decker3 in 1998, some guidelines on how the EU Member States should deal with the 
issue of cross-border healthcare. In its rulings the Court used the Treaty rules on free 
movement and the creation of an internal market to extend the right of the individuals to 
seek healthcare services cross-borders and get the costs reimbursed by the home 
Member State. The Court stated that although national rules on social security were in 
line with the social security Regulation, the national rule could still constitute a 
restriction to the right to free movement. The jurisprudence of the Court on cross-border 
healthcare services has, over the years, gradually extended the rights of individuals to 
seek reimbursement for treatment in another Member State. This has consequently lead 
to a need for the EU to adopt legislation to coordinate and clarify the patients’ rights. 
The European Union adopted in March 2011 Directive 2011/244 on the application of 
patients’ rights in cross border healthcare (the patients’ rights Directive) with the 
purpose of establishing a Community framework facilitating access to safe and high-
quality cross-border healthcare. The Directive codifies the old case law from the Court 
of Justice on cross-border healthcare services, which should create accountability and 
transparency for patients who wish to seek healthcare cross borders. The main rule laid 
down in the Directive is that patients shall in principle be free to seek healthcare to 
another EU Member State, and get the costs reimbursed by the home State. The 
Directive allows the Member States to limit the application of the rule, e.g. by 
overriding reasons of general interest and by introducing a system of prior 
authorization. The Directive also includes new rules promoting cooperation and mutual 
assistance in healthcare between the Member States.  
 
                                                 
2
 Case C-158/96 Kohll v Union des Caisses de Maladie [1998] ECR I-1931  
3
 Case C-120/95 Nicolas Decker v Caisse de maladie des employés privés [1998] ECR I-1831  
4
 Directive 2011/24 of 9 March 2011 of the European Parliament and the Council on the application of 
patients’ rights in cross-border healthcare (OJ L 88, 4 April 2011 p.45)  
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1.2 The research question 
Healthcare has traditionally been provided on a territorial basis, where patients 
contribute to a national system either through taxation or by paying premiums into an 
insurance scheme. In return the individuals receive relevant healthcare by a locally 
based healthcare provider.5 The European Union has, due to a need for legal clarity 
regarding the individual right to seek healthcare in another EU Member State, adopted a 
Directive on patients’ rights in cross-border healthcare.  
This dissertation will discuss the Court’s rulings on cross-border healthcare that lead to 
the new Directive. It will discuss how the rules of the new Directive on cross-border 
healthcare will influence the rights of individuals to reimbursement for healthcare 
services obtained cross country, and the relationship between the new Directive and the 
Court’s previous rulings. Hereunder it will be discussed whether the rules in Article 8 
on prior authorization change the legal situation from how the Court previously 
interpreted it. Furthermore, the legal opportunity of the European Union to legislate the 
healthcare area and the relation between the new Directive and the existing social 
security coordination Regulation will be discussed.  
 
1.3 Scope and limitations 
In this dissertation the focus will primarily be on EU law and the Court interpretation of 
the law. However, references will be made to national rules where appropriate.  
 
In the Court's judgments the Court has stated that the Treaty rules on free movement 
affect the right to seek healthcare services cross-borders. The Court has also ruled that 
other Treaty rules of economic nature can affect that right, such as the rules on 
competition, state aid and public procurement, but those rules mostly affect the national 
rules on healthcare. These areas will not be addressed in this dissertation.  
 
                                                 
5
 Barnard, Catherine. The Substantive law of the EU, the four freedoms. 3rd edition. Oxford, (Oxford  
University Press) 2010, p.395 
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The service providers’ right to establishment in another Member State according to 
Article 49 TFEU will not be discussed specifically.  
 
1.4 Methology and sources 
For the writing of this dissertation information has been gathered from a variety of 
sources. These include academic literature, judgments, EU legislation and preparatory 
documents.  
 
Directive 2011/24 on the patients’ rights in cross-border healthcare has recently been 
adopted, and there is not much academic literature to find on the substance of the 
Directive. Preparatory documents for the Directive and previous judgments of the Court 
of Justice in the area of cross-border healthcare are, therefore, the main sources of 
reference for the Directive’s interpretation.  
 
Citations will generally be made to the Articles of the current Treaties and secondary 
legislation, older references will however be included where relevant.  
 
The EU Treaties, the Treaty on European Union (TEU)6 and the Treaty on the 
Functioning of the European Union (TFEU)7 set out the organization and competence of 
the European Union. The main rules of relevance for this Dissertation are the rules of 
the TFEU. For practical purposes, when reference is made to “the Treaty” it is the 
TFEU that it is being referred to.  
 
1.5 Structure 
This dissertation is divided into 6 chapters. The first chapter is an introduction to the 
work, and includes introduction to the main topic, the research objectives and 
methodology. In chapter two the rules of the Treaties will be explored in order to 
establish whether the Union has competence to regulate in the area of healthcare. In that 
chapter the relevant rules of the social security Regulation will also be addressed. In the 
                                                 
6
 Treaty on European Union (OJ C 83 of 30 March 2010 p.13) 
7
 Treaty on the Functioning of the European Union, signed in Lisbon (OJ C 83 of 30 March 2010 p.47) 
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third chapter important case law from the Court of Justice and the EFTA Court will be 
discussed. The arguments set out by the courts will be explored with the purpose of 
establishing how the rulings have extended the competence of the Union by referring to 
the internal market rules of the Treaty. The mentioned chapters are all necessary in 
order to contextualize the Directive on patients’ rights in cross-border healthcare, as 
well as to understand the rules set out in the Directive. In chapter four Directive 
2011/24 on patients’ rights in cross-border healthcare is introduced and in the following 
chapter the main focus will be on Articles 7 and 8 of the Directive, i.e. the right to 
reimbursement of healthcare expenses obtained in another EU Member State, and the 
prerequisite of prior authorization. The last chapter will include the conclusion and 
concluding remarks.   
 
 
 6
2 The European Union and healthcare 
The Treaty on European Union defines in its preamble and introductory section the 
aims, goals and values of the European Union and of the European Community. Article 
3 of the Treaty sets out the tasks for the Union and explains the main purpose of the EU. 
Paragraph 3 of the Article concerns the creation of an area without internal frontiers:  
 
The Union shall establish an internal market. It shall work for the 
sustainable development of Europe based on balanced economic growth 
and price stability, a highly competitive social market economy, aiming at 
full employment and social progress, and a high level of protection and 
improvement of the quality of the environment. It shall promote scientific 
and technological advance. 
(…)  
One of the main tasks of the Union shall, therefore, be the creation of an internal 
market. The internal market rules and the application of those rules on cross-border 
healthcare form the starting point of this overview of the legal tools that the Union has 
to regulate in the area of healthcare.  
 
2.1 The competence of the European Union to act in the field of healthcare 
The powers of the European Union to regulate certain areas of the Member State’s 
internal law are governed by the Treaties. The EU institutions may not adopt any new 
law or policy that exceeds the powers given to them by the EU Member States. The 
power to regulate certain areas of the Member State’s law is mainly in three ways as set 
out in Articles 3, 4 and 6 of the Treaty. Either the competence is primarily at EU level, 
where the EU alone is able to legislate and adopt binding acts. The Member States role 
is then limited to applying these acts, unless the Union authorizes them to adopt certain 
acts themselves. This exclusive competence is considered necessary in areas such as 
those affecting the customs union and the monetary policy. Oppositely, the competence 
can be primarily on the Member State level, where the Member States retain most of the 
 7
legislative power to adopt binding acts. Consequently, the EU has no legislative power 
in these fields and may not interfere in the exercise of these competences reserved for 
the Member States. The EU may only act in order to support, coordinate or complement 
the action of Member States. This shall apply in areas such as protection and 
improvement of public health and education. The third possibility is where the EU and 
the Member States share the competence, and are both authorized to adopt binding acts. 
The Member States may however only exercise their competence in so far as the EU 
has not exercised, or has decided not to exercise its own competence. This can be in 
areas such as those affecting the internal market, social policy and consumer 
protection.8 
To find out at what level of governance the legislative competence is in the area of 
health and healthcare law, one has to examine the EU Treaties and the rules set out in 
them regarding this area of law. This exercise will also give an indication of how much 
economic and social integration there may be expected in the healthcare area. In the 
next subchapter the competence resulting from the Treaties and secondary legislation 
will be explored.   
 
2.2 The Treaties 
It has been much debated whether the European Union has competence to act in the 
area of healthcare. In the original EEC treaty that created the European Community, the 
Treaty of Rome of 1957, only limited reference was made to health. This was done by a 
reference either to “protection of health” or “public health”9, and prior to the Treaty of 
Maastricht10 the EU institutions had no clear competence in the field of health.11  
                                                 
8
 Division of competences within the European Union, accessible at: 
http://europa.eu/legislation_summaries/institutional_affairs/treaties/lisbon_treaty/ai0020_en.htm  - last 
visited 22 October 2011 
9
 Reference was made to health in Articles 36, 48(3) and 56(1) 
10
 Treaty on European Union, signed in Maastricht (OJ C 325 of 24 December 2002, p.5) 
11
 Hervey, Tamara K. and McHale, Jean V. Health Law and the European Union. Cambridge, 
(Cambridge University Press) 2004, p.72 
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Since then there have been several Treaty amendments and in the process the focus has 
moved towards creating an area of law where the competence to act is shared between 
the EU and the Member States.12 The Lisbon Treaty of 2009 represents the final step in 
the process of integrating health services in the European Union. The Treaty 
amendments have also taken into consideration the Court interpretation of the 
fundamental principles of EU law and their interaction with healthcare services.13  
As is stated in Article 4 of the TFEU, the competence in public health matters shall be 
shared between the EU and the Member States. It is then stated in Article 6 TFEU that 
the Union shall have competence to carry out actions to support, coordinate or 
supplement the actions of the Member States regarding the protection and improvement 
of human health. Article 3 TFEU, which refers to the areas where the Union has 
exclusive competence, does not include health.  
In title XIV of the TFEU, Article 168 concerns public health. The Article mainly 
provides for cooperation between the Member States in the area of health, as well as 
stating that Union action shall complement the national policies. The first paragraph of 
the Article states that high level of health protection shall be ensured in all Union 
policies and action. The concluding paragraph states that Union action shall respect the 
responsibilities of the Member States for the definition of their health policy, and for the 
organization and delivery of health services and medical care. The Article also states 
that, included in the Member States responsibilities shall be the management of health 
services and medical care and the allocation of resources assigned to them. This 
concluding paragraph of Article 168 shows how the real responsibility of organizing 
and delivering healthcare lies with the Member States themselves, and that the 
competence of the Union is limited in that regard.  
The internal market legal base is to be found in Article 114 TFEU. In Article 114(3) it 
is stated that, when measures adopted by the Union aim at establishing or ensuring the 
functioning of the internal market, they must guarantee a high level of protection of 
health.  
                                                 
12
 For detailed information about the Treaty amendments see Hervey, Tamara K., op. cit. n.11 p.72-81 
13
 Health care and EU law, Johan Willem van de Gronden … [et al.]. The Hague, (T.M.C. Asser Press) 
2011, p.22 
 9
As seen from the mentioned Articles of the Treaty it is clear that the European Union 
and the Member States shall share competence in the area of common safety concerns 
in public health matters. It is also clear that the Union shall have the competence to 
carry out actions to support, coordinate or supplement the actions of the Member States 
regarding the protection and improvement of human health. Following the TFEU the 
Member States, therefore, do not in any regard hold exclusive competence in the area of 
health.14  
To summarize the competence gained from the Treaties, it appears that the line dividing 
the competence to regulate in the area of healthcare between the Member States and the 
EU is blurred. The competence conferred on the EU by the Treaties has, however, 
expanded over time and the Union has therefore gained increased powers to regulate in 
this area of law. Professor Wyatt15 has written that the Union competence to regulate 
medical services based on Article 114 will much depend on the specific subject matter 
under consideration. He considers that medical services are in principle open to 
regulation by harmonization measures adopted by the Union institutions under Article 
114, but only up to the extent that medical services are considered services within the 
meaning of Article 56.  
This area of law has over the years become of bigger interest to the EU. Consequently, 
the Member States have shown more interest in retaining their powers to control and 
regulate this area, as healthcare expenditure is a big proportion of the national budget.  
 
2.2.1 National autonomy over the healthcare systems 
It follows from Article 168(7), and has been confirmed in many rulings from the Court 
of Justice, that the EU shall respect the powers of the Member States to organize their 
social security systems, and the delivery of healthcare services and medical care.16   
                                                 
14
 van de Gronden, Johan Willem ... [et al.] (2011) op. cit. n.13, p.23 
15Social Welfare and EU Law. Edited by Michael Dougan and Eleanor Spaventa, Hart Publishing, Oxford 
and Portland, Oregon (2005) p.142-143  
16
 Case C-238/82 Duphar BV and others v The Netherlands State [1984] ECR 523, para 16, Joined cases 
C-159&160/91 Christian Poucet v Assurances Générales de France and Caisse Mutuelle Régionale du 
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The Court of Justice has consistently stated in its rulings that where an area of law is not 
harmonized at EU level, it is for the Member State to determine its nation rules. It has 
stated that it is, therefore, for the Member States to determine (i) the conditions 
concerning the right or duty to be insured with a social security scheme,17 (ii) which 
insurance schemes are provided and (iii) the conditions for entitlement to benefits18.  
 
2.3 The social security coordination Regulation 
The original right to receive healthcare in another Member State at the expense of the 
home State was set out in Regulation 1408/7119 on the application of social security 
schemes to employed persons and their families moving within the Community, and 
Regulation 574/7220 implementing the former. The Regulations were replaced by the 
social security coordination Regulation 883/200421 and the implementing Regulation 
987/200922, which entered into force in May 2010. The new legislative package has 
been referred to as “modernized coordination” of the social security systems in the 
EU.23  
                                                                                                                                               
Languedoc-Roussillon and Daniel Pistre v Caisse Autonome Nationale de Compensation de l' Assurance 
Vieillesse des Artisans [1993] ECR I-637, para 6, Decker, op. cit. n.3, para 21, Kohll, op. cit. n.2, para 17, 
Case C-157/99 Geraets-Smits v Stichting Ziekenfonds VGZ and Peerboms v Stichting CZ Groep 
Zorgverzekeringen [2001] ECR I-5473, para 44, Case C-372/04 Yvonne Watts v. Bedford Primary Care 
Trust [2006] ECR I-4325, para 92 
17
 Case 110/79 Coonan v Insurance Officer [1980] ECR 1445, para 12, Kohll, op. cit. n.2, para 18, 
Decker, op. cit. n.3, para 22, Smits and Peerboms, op. cit. n.16, para 45, Case C-56/01 Patricia Inizan v 
Caisse primaire d'assurance maladie des Hauts-de-Seine [2003] ECR I-12403, para 17, Case C-385/99 
Müller-Faure v Onderlinge Waarborgmaatschappij OZ Zorgverzekeringen UA and van Riet v 
Onderlinge Waarborgmaatschappij ZAO Zorgverzekeringen [2003] ECR I-4509, para 100 
18
 Joined cases C-4&5/95 Fritz Stöber and Jose Manuel Piosa Pereira v Bundesanstalt für Arbeit [1997] 
ECR I-511, para 36, Kohll, op. cit. n.2, para 18, Decker, op. cit. n.3, para 22, Watts, op. cit. n.16, para 92 
19
 Regulation 1408/71 of the Council of 14 June 1971 on the application of social security schemes to 
employed persons, to self-employed persons and to members of their families moving within the 
Community (OJ L 149 of 5 July 1971, p.2) 
20
 Regulation 574/72 of the Council of 21 March 1972 laying down the procedure for implementing 
Regulation 1408/71 (OJ L 74 of 27 March 1972, p.1) 
21
 Regulation 883/2004 of the European Parliament and of the Council of 29 April 2004 on the 
coordination of social security systems (OJ L 166 of 30 April 2004, p.1)  
22
 Regulation 987/2009 of the European Parliament and of the Council of 16 September 2009 laying 
down the implementing procedure for Regulation 883/2004 (OJ L 284 of 30 October 2009, p.1)   
23
 Cross-border health care in the European Union. Edited by Matthias Wismar … [et al]. World Health 
Organization on behalf of the European Observatory on Health Systems and Policies, 2011, p.6  
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In the EU, the various social security systems are coordinated by the Regulations but 
not harmonized. When Regulation 1408/71 was put in place, it was intended to establish 
entitlements to social security benefits for citizens moving to another Member State.  
The social security Regulation is, on the other hand, considered to be more of a “safety 
net”24 as it guarantees patients’ minimum rights to access healthcare in another Member 
State if they cannot access the necessary care in their home State.  
Regulation 1408/71 was amended regularly, partly in order to take into consideration 
the Court jurisprudence on healthcare services. The difference between the old and the 
current social security Regulations is not significant for the purposes of this dissertation. 
The main difference is that the administrative processes have been improved in order to 
make the individual rights following the Regulation more effective and user friendly for 
the citizens.25  
The current social security Regulation has a broader personal scope than its 
predecessor. The Regulation applies both to nationals of a Member State and stateless 
persons and refugees residing in the Member State, who are or have been subject to the 
legislation of one or more Member States, as well as to the members of their families 
and to their survivors. Regulation 1408/71 was originally limited to employed persons 
but the scope was later broadened so that it also applied to self-employed persons, civil 
servants and students.  
The various categories of benefits covered by the coordination Regulation are defined 
in Article 8. When a person relies on the Regulation for entitlement to benefits, the 
mechanism of the Regulation seeks to answer three key questions that explain the 
individual’s social security coverage, (i) in what Member State and under which 
conditions is an entitlement to healthcare benefits in kind opened (ii) which legislation 
determines the scope of the entitlement to benefits and (iii) what Member State will 
have to cover the costs?26   
                                                 
24
 European Commission communication, A Community framework on the application of patients’ rights 
in cross-border healthcare, COM (2008) 415 final of 2 July 2008, p.5 
25
 Matthias Wismar … [et al.], op. cit. n.23, p.6 
26
 Elias Mossialos ... [et al.], op. cit. n.1, p.514 
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Chapter 1 of Title III of Regulation 883/2004 concerns sickness benefits. A person 
seeking healthcare in another Member State can according to that chapter of the 
Regulation be entitled to benefits in kind. Benefits can generally be provided by two 
means; benefits in kind or benefits in cash. Sickness benefits in cash are intended to be 
an income replacement, while sickness benefits in kind are linked to personal services 
(e.g. medical treatment) and remedies and aids (e.g. crutches or wheelchairs).27  
Of relevance to the topic of this Dissertation are Articles 19 and 20 of the Regulation. 
Article 19 concerns treatment that becomes necessary when the patient is on a short 
term stay in another Member State, and Article 20 deals with the rights of patients that 
travel to another member State with the purpose of seeking medical treatment.  
 
2.3.1 Necessary treatment during a short term stay in another Member State 
In the situation when a persons’ medical condition requires benefits in kind which 
become necessary during a temporary stay in another Member State, the necessary 
treatment is guaranteed by Article 19 of the Regulation. In such circumstances, a 
European Health Insurance Card (EHIC) issued by the competent institution of the 
home State, indicating the right to benefits in kind, shall be presented to the healthcare 
provider in the EU Member State where emergency treatment is needed.28  
Given that conditions set out in Article 19 are fulfilled, the patient is entitled to benefits 
in kind that are provided on behalf of the home State. The benefits are provided by the 
institution in the place of stay and in accordance with the legislation which it 
administers as though the person was insured under the system of that Member State. 
Under these circumstances no authorization for treatment is required by the home State. 
The patient pays for the healthcare as if he was insured in that Member State where the 
                                                 
27
 Zaglmayer, Bernhard and Einarsson, Olafur, Access to and Reimbursement of Health Care in the 
European Economic Area, (2009) Tidsskrift i Erstatningsrett – nr. 3 2009/årgang 6, chapter 2.2  
28
 Article 25 A (1) of Regulation 987/2009 laying down the implementing procedure for Regulation 
883/2004 (OJ L 284 of 30 October 2009, p. 1). If the insured person has no such document the institution 
of the place of stay can, if needed, contact the competent institution of the home State to obtain 
confirmation of insurance.  
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treatment is received. The competent authorities of the affected Member States may 
then create a system of reimbursement between them according to Article 35 of the 
Regulation.29 
 
2.3.2 Planned treatment in another Member State 
Article 20 of the Regulation sets out in its first paragraph, that an insured person 
travelling to another Member State with the purpose of receiving benefits in kind during 
the stay shall seek prior authorization from the competent institution in the home State. 
Following the Article, prior authorization is, therefore, a prerequisite for getting the 
costs for treatment abroad reimbursed.  
Paragraph 2 of the same Article concerns the rights of a person who has received 
authorization to seek healthcare in another Member State. The person shall receive the 
benefits in kind that are provided by the institution in the place where the treatment is 
sought and in accordance with the legislation it applies, as if the patient was insured 
under that legislation. The benefits are provided by that State, on behalf of the home 
State. Where the authorization has been granted, the costs for the treatment are mostly 
paid directly by the institution in the home State where the person is insured, to the 
foreign healthcare provider.     
The home State has a duty to grant the prior authorization where the treatment needed 
(i) is amongst the benefits provided for in the legislation of the home Member State and 
(ii) where the necessary treatment cannot be given at home within a medically 
justifiable time limit. When evaluating the need for treatment abroad the patients’ 
current state of health and the probable course of the illness shall be taken into account. 
The Regulation follows the principle repeatedly confirmed by the Court of Justice that 
Community law does not detract from the power of the Member States to organize their 
social security systems.30 The Regulation is therefore not intended to affect the core of 
                                                 
29
 Article 25 B (4) and (5) of Regulation 987/2009 op. cit. n.28, explains a different procedure of 
reimbursement of medical expenses obtained abroad in the situation where the patient has actually borne 
the cost of all, or part, of the treatment received abroad 
30
 Op. cit. n.16  
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the national rules, inter alia, on what healthcare it makes available to its citizens. It 
does, however, establish some degree of coordination between the various social 
security systems and secures minimal social and healthcare benefits for all. The 
medically justifiable time limit has been interpreted by the Court as situations where a 
patient is facing “undue delay” for necessary treatment at home. In these circumstances 
the home State is in breach of the Regulation by refusing authorization.  
When authorization has been given according to Articles 19 and 20 of the Regulation, 
the competent institution of the home Member State has, according to Article 35, the 
duty to reimburse fully the costs for the treatment to the competent institution in the 
State of treatment. The implementing Regulation 987/2009 sets out in Article 62 the 
principles for reimbursement of costs between the relevant institutions.  
In the cases of Kohll and Decker, Regulation 1408/71 was challenged based on the 
Treaty rules on free movement. The relevant cases concerning the internal market rules 
and how they interact with the rules of the social security coordination Regulations will 
be discussed in the next chapter.  
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3 The European Union market rules 
The starting point of the influence of EU law on health and healthcare was with the 
application of the internal market rules on this sector. EU market rules, e.g. the free 
movement rules, competition law and other EU law of economic nature are rules that 
can interfere with the national organization of healthcare. The rules can produce 
disruptive effects and challenge the national solidarity, that healthcare services are 
based on.31 
 
3.1 Interaction with the internal market 
The internal market of the European Union is based on four freedoms: free movement 
of goods, persons, services and capital. In the seminal rulings in the cases of Kohll and 
Decker the Court applied the Treaty provisions on free movement, and considered 
healthcare services to be services of economic nature. The economic nature of the 
service is the only determining criterion to confirm if the service comes under the scope 
of the Treaty provisions on free movement of services.32 By referring to the free 
movement provisions in the Treaty [EC Treaty] the Court gave signals indicating that 
national healthcare and especially the Member States organization of healthcare (such 
as planning), can be affected by the application of EU law.33  
The Court could have rejected the application of Articles 56 and 57 TFEU on national 
healthcare by arguing that healthcare did constitute an economic activity. The Court 
however stated that the Treaty rules on the internal market applied to healthcare 
services and that the Member States could use the public interest requirements to 
reconcile restrictions to the principle of free movement.34  
                                                 
31
 van de Gronden, Johan Willem ... [et al.] (2011) op. cit. n.13, p.3 
32
 Elias Mossialos ... [et al.], op. cit. n.1, p.465 
33
 van de Gronden, Johan Willem ... [et al.] (2011) op. cit. n.13, p.2  
34
 Barnard, Catherine, op. cit. n.5, p.396 
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Public education is something that might be considered by many to fall in the same 
category as healthcare services. The Court however excluded education services from 
the scope of the free movement of services in the cases of Humbel35 and Wirth36, as the 
public education system did not constitute services of economic character. In these 
rulings the Court mainly referred to the fact that (i) in services, the price is normally 
agreed upon between the provider and the recipient of the service, and the Court 
considered that characteristic absent when services are provided under the national 
education system, (ii) the State, when establishing and maintaining the national 
education system, is not seeking to engage in gainful activity, but is fulfilling its duties 
towards its own population in the social, cultural and educational fields, and (iii) the 
education system is generally financed from the public purse.37  
 
3.1.1 Free movement of services 
When considering the legal framework for cross border healthcare Articles 56 and 57 
TFEU on the free movement of services are of relevance. Article 56 prohibits 
restrictions on the freedom to provide services within the Union, while Article 57 
explains what services come within the scope of the Treaty. Services are economic 
activities, and shall particularly include activities of industrial or commercial character, 
activities of craftsmen or of the professions, normally provided for remuneration, in so 
far as they are not governed by the provisions relating to freedom of movement for 
goods, capital or persons. To fall within the Treaty, the service must therefore be 
provided for remuneration, i.e. there needs to be an economic link between the service 
provider and recipient.38   
In its rulings the Court has found that the Treaty rules on services are relevant when EU 
nationals travel to another Member State to receive medical treatment, because medical 
services constitute ‘services’ within the meaning of Article 57 TFEU. This was first 
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stated by the Court in the breakthrough case of Luisi and Carbone39 of 1984, where the 
Court ruled that it is not only the providers of services that are within the scope of 
protection but also the recipients. The Court did, however, say that the freedom to 
provide and receive services may be restricted, and explained that the Member States 
can justify such restrictions on grounds of public policy, public security and public 
health.40 
An important ruling was given in the previously mentioned case of Kohll.41 Mr Kohll, a 
Luxembourg national, brought his daughter to a dentist established in Germany without 
seeking prior authorization as required by national law when treatment was sought 
abroad. When the same treatment was acquired domestically no prior authorization was 
required. Mr Kohll was refused authorization and the case was brought to the Court of 
Justice, where Mr Kohll asserted in particular that the Luxembourg authorities had only 
considered whether the national rules were consistent with the social security 
Regulation [1408/71] but not whether they were consistent with Articles 56 and 57 [59 
and 60] of the Treaty.   
The Court, with reference to Mr Kohll’s arguments, found that the fact that the national 
rules at issue fall within the sphere of social security cannot exclude the application of 
the Treaty rules on free movement of services.42 The Court furthermore found that the 
national rule on prior authorization would make it more difficult to approach a service 
provider established in another Member State, than one providing the service within the 
same Member State. The national rule would therefore deter insured persons from 
seeking medical services in another Member State and would, consequently, constitute 
a barrier to the freedom to provide services.43 The Court then went on to examine 
whether the national measure could be objectively justified.   
The Luxembourg authorities argued that requiring prior authorization was an effective 
way of preventing the risk of upsetting the financial balance of the social security 
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scheme. They furthermore claimed that the national rule of prior authorization aimed at 
ensuring a balanced medical and hospital service available to all insured persons, which 
constituted an overriding reason capable of justifying restrictions on the freedom to 
provide services. The Court considered this argument and found that as Mr Kohll was 
asking for reimbursement at the same rate as applied in Luxembourg there was no 
significant effect on the financing of the social security system.44  
The Luxembourg authorities also argued that the rule could be justified on public health 
grounds in order to ensure the quality of medical services. The Court, however, found 
that since the conditions for taking up and exercising professional activities of health 
professionals had been subject to EU harmonization directives, the quality of the service 
was guaranteed.45  
On these grounds the Court found that the national rule requiring prior authorization 
was in breach of the Treaty rules on free movement of services.  
This ruling lead to a situation where the coordination Regulation (art. 22(2) of Reg. 
1408/71, now art. 20 of Reg. 883/2004), requiring prior authorization for 
reimbursement, and the Treaty rules now were in conflict with each other. The Court 
continued and explained that although a national measure may be consistent with 
secondary legislation from the EU, it may still be incompatible with the Treaty. The 
Treaty is a higher norm than the secondary legislation, and as confirmed in this case, 
Articles 56-57 of the Treaty are able to reshape and override the social security 
coordination Regulation, and subsequently other secondary legislation from the EU.   
The case of Decker46 also concerned Luxembourg national rules, where Mr Decker 
asked for reimbursement for spectacles bought in Belgium. The Court used the same 
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arguments as in the Kohll case, but this time the Court found that the national measure 
was contrary to the Treaty rules on the free movement of goods, Articles 34 and 36 [30 
and 36 ]. 
The cases of Kohll and Decker show that making the reimbursement of healthcare 
expenses obtained in another EU Member State completely dependent on prior 
authorization is a breach of the Treaty rules on free movement. These rulings of the 
Court introduced an alternative procedure for the reimbursement of expenses for 
healthcare received in another Member State. The original route, created by the social 
security Regulation, provides for full reimbursement of the costs, whereas the Treaty 
route, based on the free movement of services, only provides for reimbursement up to 
the level of what the healthcare would have cost had it been provided at home.  
The mentioned cases of Kohll and Decker created strong reactions by the national 
authorities and others involved in organizing, financing and providing healthcare.47 The 
rulings suggested that in respect of healthcare provided outside of a hospital, the 
requirement of prior authorization could not be justified. This would seemingly entitle 
patients to demand treatment in other Member States and be reimbursed for the costs of 
the treatment by the competent authority in the home State. Following the rulings this 
seemed to be a judicially enforceable right. The cases, however, left some questions 
unanswered, e.g. whether the same rules applied to hospital treatment, and whether the 
principles laid down in the cases applied to a system based on benefits in kind rather 
than on reimbursement.48 These questions were considered by the Court in its later 
rulings.  
In the Court ruling in Vanbraekel49 the importance of what the Treaty provisions could 
achieve was seen again. The case concerned a woman insured in Belgium, who had 
received hospital treatment in France and was wrongfully denied prior authorization. 
The authorization was later approved, and the question raised for the Court was whether 
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the reimbursement should be calculated according to the tariffs in the host State, where 
she was treated, or of the State of residence, where she was insured.   
The Court looked at Article 20 of the social security coordination Regulation [22(1)(c) 
of Regulation 1408/71] and Article 56 [59] of the Treaty. The Regulation provided that 
when an insured person has been authorized by the home State to seek treatment in 
another member State, the institution in the place where the treatment is given should 
provide the person benefits in kind, in accordance with its rules as if he the person was 
insured in that State. This should be provided on behalf of the competent institution of 
the home State and only the length of the period during which benefits are provided 
remains to be governed by the legislation of the home State.  
The Court stated that when such an authorization had been wrongfully refused, and later 
found that the refusal had been unfounded, the person is entitled to be reimbursed 
directly by the competent institution of the home State. The amount to be reimbursed 
should be equivalent to that which had been paid had the authorization been properly 
granted in the first place.50 In this case it meant reimbursement under the French rate, 
which was lower than the Belgian rate that would have applied had the treatment been 
provided at home.  
The Court applied Article 56 [59] of the Treaty to fill the gap and started by stating that 
it was settled case law that medical activities fall within the scope of the Treaty rules on 
free movement of services. The Court continued and found that there was no need to 
distinguish between care provided in a hospital and care provided outside such 
environment.51 The Court then noted that if patients had a lower level of cover when 
they receive hospital treatment in another Member State than they would in the Member 
State where they are insured, it could have the effect of preventing persons from 
applying to providers of medical services established in other Member States. That 
would constitute a barrier to the freedom to provide services, both for insured persons 
and for service providers.52  
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The Court found, that where the amount of reimbursement is less if calculated 
according to the scheme of the Member State of treatment than if calculated according 
to the scheme of the home Member State, additional reimbursement covering the 
difference must be granted.53 Article 56 [59] therefore required reimbursement at the 
rate of the more beneficial State.  
In the Smits-Peerboms54 judgment the requirement of prior authorization to seek 
hospital service in another Member State was challenged under the Treaty rules on 
services. The Court confirmed (as it did in Vanbraekel that was published at the same 
day) that there was no need to distinguish between care provided within a hospital and 
care provided outside hospital.55  
The Court furthermore found that Articles 56 and 57 TFEU [59 and 60] did not 
preclude legislation that makes the reimbursement of costs of treatment in another 
Member State subject to prior authorization. The Court explained that such 
authorization could be made subject to the conditions that; the treatment must be 
regarded as “normal in the professional circles concerned” and the persons’ medical 
condition must require the treatment. The Court however found that this only applied so 
far as the requirement that the treatment must be regarded as “normal”, cannot be 
refused on that ground where it appears that the treatment concerned is sufficiently tried 
and tested by international medical science, and it can only be refused on the ground of 
lack of medical necessity if the same or equally effective treatment is available at 
home.56 
The Court therefore approved the refusal to provide prior authorization when the 
treatment sought is experimental or not scientifically proved, and when the same or 
equally effective treatment can be provided by a nationally based provider.  
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Along the same line are the joined cases of Rindal and Slinning57 from the EFTA 
Court.58 The cases both concerned Norwegian citizens seeking treatment abroad, 
requesting reimbursement from their national authorities. The EFTA Court considered it 
compatible with the rules of the EEA Agreement to refuse to cover expenses for 
medical treatment abroad “which according to international medicine must be 
considered experimental or test treatment when there is no entitlement to such treatment 
in the home State”.59  
In the case of Müller-Faure and van Riet,60 the Court confirmed its previous ruling in 
the case of Smits and Peerboms, that hospital treatment falls within the rules in Articles 
56 and 57 [59 and 60].61 The Court also found that the requirement of prior 
authorization constitutes a barrier to the freedom to provide services, both for the 
insured person and the service provider. The Court ruled that the Treaty rules must be 
interpreted as not precluding legislation of a Member State which (i) makes the 
assumption of the costs of care provided in a hospital in another Member State by a 
healthcare provider that the insurance fund has not concluded an agreement, conditional 
upon prior authorization by the fund and (ii) makes the grant of the authorization 
subject to the condition that the treatment is necessary for the insured persons health.62 
However, authorization may be turned down if treatment which is the same or equally 
effective for the patient can be obtained without undue delay in an establishment which 
has concluded an agreement with the fund.63 This was later also confirmed in the Court 
ruling in the case of Inizan64.  
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In the case of the 72 year old Yvonne Watts65 the requirement of prior authorization 
could not be justified by the UK authorities. Ms Watt was diagnosed with osteoarthritis 
and was facing a one year wait for a hip replacement at her local hospital. Despite being 
refused to seek treatment abroad she travelled to France to have the operation done. The 
Court confirmed that patients facing “undue delay” at home, defined by their clinical 
condition rather than potentially arbitrary targets, may travel to another Member State 
for treatment and expect to receive reimbursement for the costs of treatment because of 
the undue delay.  
The case Commission v France66 concerned French rules that required anyone going 
abroad for diagnosis or treatment that needed “major medical equipment” to seek prior 
authorization if they were to be reimbursed. Here the Court confirmed that the 
requirement of prior authorization for treatment given outside of a hospital could be 
justified by the need to protect the financing of the health insurance system and to 
ensure proper planning of such equipment. It also noted that the prior authorization 
requirement was considered necessary in order to ensure a rationalized, stable, balanced 
and accessible supply of up to date treatment throughout the national territory and to 
avoid, so far as possible, any waste of financial, technical and human resources.67 The 
Court referred to this ruling in the case Commission v Portugal68 decided on 27 October 
2011 which is the latest healthcare case of relevance to this dissertation. The Court 
stated that a Portuguese rule restricting reimbursement of non-hospital care that requires 
the use of major and costly equipment could be justified.  
 
3.2 Summary of the case law – what does it tell us? 
To conclude this overview of the relevant case law from the Court of Justice and the 
EFTA Court in the area of cross-border healthcare, it is clear that many questions still 
need to be answered or have unclear answers. Uncertainty about the entitlements to 
                                                 
65
 Watts, op. cit. n.16 
66
 Case C-512/08 European Commission v French Republic [2010] ECR I-1297 
67
 Ibid, para 26-43 
68
 Case C-255/09 Commission of the European Communities v Portuguese Republic [2011] ECR I- Has 
not been published 
 24
reimbursement for cross-border healthcare can lead to reluctance by patients to seek 
healthcare abroad. This uncertainty can also create problems for the national authorities 
when organizing their healthcare systems.  
In the mentioned cases the national organization of healthcare and the social security 
coverage is not an issue, as this is to be determined by the Member States themselves.69 
Individuals are in principle free to travel abroad and to seek medical care from whatever 
provider they choose. However, the case law tells us that this principle in practice is 
limited either to the ability of the patient to pay for the care, or by national and/or EU 
legislation that create conditions where patients are entitled to reimbursement of the 
expenses.  
The Court has made clear that all medical services, whether provided inside a hospital 
or outside of a hospital environment, constitutes services within the meaning of Article 
56 TFEU and do therefore fall within the scope of the Treaty.70 However, in the 
judgments, the Court has made a distinction between treatment provided in or outside of 
hospital and found that hospital treatment may be subject to prior authorization.  
The Court has found that the requirement of prior authorization, that is always required 
as a condition for reimbursement under the text of the social security Regulation, is per 
se a barrier to the freedom to provide services. This applies both to the freedom of the 
insured person and the service provider, as the national measure deters insured persons 
from approaching providers established in another Member State.71 The prior 
authorization requirement is considered to be justified based on reasons such as to 
safeguard the financial balance of the national social security system and planning in 
the hospital sector.  
According to the case law, the Member States are allowed to maintain barriers to the 
free movement of services provided that they are justified in the public interest. The 
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Member States must prove that the measure is objectively necessary for ensuring the 
attainment of a public interest objective (necessity test), and that it does not exceed 
what is necessary to attain the objective, or that the same result can be achieved by a 
less restrictive rule (proportionality test) as well as the measure shall be applied in a 
non-discriminatory manner.72  
Prior authorization can be refused when the treatment sought is regarded as 
experimental or not scientifically proved, or when equally effective treatment can be 
provided by a nationally based provider within a medically justifiable time limit.73 The 
Court has also accepted the legality of national rules requiring patients going abroad for 
diagnosis or treatment that needs “major medical equipment” to seek prior 
authorization.74 The Court has also stated that the Member States cannot purely rely on 
the presence of waiting lists as part of a complex planning as an excuse to refuse to 
deny prior authorization.75   
The concept of “undue delay” has been a critical element of many cases before the 
Court. The Court confirmed in Watts that patients facing “undue delay” for treatment at 
home may access the same or equivalent services in other EU Member States and 
expect to receive reimbursement for the costs of treatment because of the undue delay.  
The Court has developed a parallel regime for patient mobility to the pre-existing 
system in the social security coordination Regulation. The case law based system of 
reimbursement is based on Article 56 of the Treaty. When the patient relies on Article 
56 TFEU, the reimbursement is made up to the level that the healthcare would have cost 
had it been provided at home. The social security coordination Regulation gives right to 
reimbursement at the rate of the State of treatment, which generally guarantees full 
reimbursement.76    
Under the Court case law on Article 56 and 57 it is the patient that bears the risk of the 
healthcare in the Member State of treatment costing more than it does in the home 
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State. If prior authorization is provided under the social security coordination 
Regulation, it is the public funds that bear the risk.  
The Directive on services in the internal market is linked to the Courts progressive 
interpretation of the application of the Treaty rules on the free movement of healthcare 
services. In the initial proposal for a Directive the Commission attempted to clarify the 
individual rights to seek healthcare cross borders.  
 
3.3 The services Directive 
When the proposal for a Directive covering services in the internal market was 
launched77 it included provisions on medical services in Article 23. The objective of 
this was to increase legal certainty in the area of cross-border healthcare. The provision 
was limited, but intended to codify the Court case law on healthcare services and was 
based on a distinction between hospital and non-hospital care.  
The European Parliament and the Council voted for taking health services out of the 
Directive. In their opinion, the proposal did not take the specific nature of health 
services sufficiently into account, especially regarding the technical complexities, and 
the fact that this area is sensitive for the public opinion, and mostly founded by public 
funds. The Commission subsequently announced that a separate and more adapted 
initiative in the area of healthcare services was to be presented.78  
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4 Directive 2011/24 on the application of patients’ rights in cross- border 
healthcare 
 
Due to all the legal uncertainties surrounding cross-border healthcare services created 
by the Court rulings, it was clear for all parties involved that there was a need for 
clarification from the EU regarding the patients’ rights. Already in 2003 the 
Commission was invited by the Health Ministers and other stakeholders to discuss how 
the legal certainty in cross-border healthcare could be improved.79 After the Parliament 
and the Council in 2006 had voted healthcare services out from the scope of the services 
Directive it became clear that a measure, specifically addressing cross-border 
healthcare, was needed.  
 
All EU institutions were involved in the preparation of the new legal framework, which 
was based on several external surveys, analyses and studies. In June 2006 the Council 
adopted a Conclusion on Common values and principles in European Union Health 
Systems80 and stated that such a Conclusion would be of particular value for the new 
legislation. The Parliament made its contributions by writing various reports. Other 
stakeholders were also actively involved in the Commission activities regarding patient 
mobility and healthcare.81 In September 2006, the Commission formally launched a 
consultation with the relevant stakeholders involved in the health services sector, and 
invited them to contribute to a consultation process regarding Community action in 
healthcare services.82 The Commission received 280 responses from various groups, 
including health professional organizations, healthcare providers, governments and 
insurers. These comments were taken into account when preparing the legislative 
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proposal.83 It was expected that the Commission would introduce the new legislative 
proposal by the end of 2007.  However, the process got delayed due to many factors 
such as internal differences within the College of Commissioners, political difficulties 
and fear that the legislative proposal would be rejected, as happened in the prior attempt 
to regulate healthcare services by addressing the issue in the services Directive.84  
 
The conclusion of the work was the adoption of a Directive and the Commission finally 
published a proposal for a Directive on the application of patients’ rights in cross-border 
healthcare in July 2008. The proposal’s aim was to establish a general framework for 
provision of safe, high quality and efficient cross-border healthcare in the European 
Union. By that, also to ensure free movement of health services and a high level of 
health protection, while fully respecting the responsibilities of the Member States for 
the organization and delivery of health services and medical care.85 The Commission 
published an Impact assessment86 along with the proposal that it had used to choose 
between different policy options. In the assessment the Commission stated that cross-
border healthcare was estimated to represent around 1% of the public expenditure on 
healthcare which is €10 billion per year.87 The Commission has forecasted that under 
the rules of the Directive that cost increase a year will only be € 30 million.88 
 
The process of adopting the Directive was long and complex, not least due to 
complications in reaching a common consensus between the Parliament and the Council 
of Ministers. In April 2009 the Parliament voted in favor of the proposal after making 
several amendments to the text.89 The adoption process was even more complicated in 
the Council, mainly caused by three points of contention. The most debated points were 
firstly, the legal base of the Directive and the principles of proportionality and 
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subsidiarity,90 and secondly whether long-term care should be within the scope of the 
Directive and thirdly under which situations the Member States could refuse to provide 
prior authorization to seek hospital care abroad.91  
 
In March 2011 the legislative act was adopted by the European Parliament and became 
law on 4 April 2011 when it was listed in the Official Journal of the European Union. 
The EU Member States are required to adopt the necessary laws, regulations and 
administrative provisions by 25 October 2013.92  
 
The Directive on patients’ rights in cross-border healthcare was introduced in the 
context of the Commission renewed social agenda in 21st century Europe.93 The 
renewed social agenda and the ideas presented along with it were intended to 
complement the Lisbon Treaty from a social perspective.  
 
4.1 Legal basis and scope 
In the initial proposal for a Directive the Commission states that it considers the 
Member States not able to sufficiently achieve the objectives of the proposal on their 
own. The Commission therefore considers, that by reason of the scale of action, the 
objectives will be better achieved at Community level, and that the principle of 
subsidiary and proportionality as set out in Article 5 of the Treaty on the European 
Union are complied with.94   
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The Directive has its legal base in Articles 114 and 168 TFEU. As explained in chapter 
2.2, Article 114 allows the Union to take action to set out harmonization measures that 
have as their objective the establishment and functioning of the internal market. 
Paragraph 3 of the Article then requires those measures to guarantee a high level of 
human health protection, taking into account in particular any new developments based 
on scientific facts. Article 168 allows the EU to act in order to complement the national 
policies and encourage cooperation between the Member States. At the same time the 
EU shall respect the responsibilities of the Member States to define, organize and 
deliver health services and medical care.  
The initial proposal for a Directive was only based on Article 114, whereas the 
Commission stated that it considered the proposal at the same time fully in line with the 
requirements set out in Article 168.95 Having a double legal base, both of the internal 
market and public health, was one of the discussion points both in the Council and the 
Parliament. The main point of disagreement was that if the Directive would only be 
based on Article 114, the free movement of healthcare services could be seen too much 
only as an economic right, which could cause healthcare service providers to focus too 
much on the customers’ buying power, rather than the patients’ medical need. Different 
interest groups also had concerns that the social nature of healthcare and the idea of 
healthcare as a service in the general interest would be lost if the proposal would only 
be put forward in the context of internal market harmonizing measures, as these 
measures are linked to the exercise of economic rights.96 The Council and the 
Parliament finally agreed on a double legal base. The Council and the Parliament 
considered that by having a double legal base, the Directive will have a balance 
between, on one hand, the application of the free movement rules of the Treaty, and on 
the other hand, the competences of the Member States in the field of healthcare 
services.97 
The scope of the Directive is defined in Article 1, and it appears to apply to all types of 
healthcare. As stated in recital 11 in the preamble to the Directive the Court has 
confirmed that neither its special nature, nor the way in which it is organised or 
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financed, removes healthcare from the ambit of the fundamental principle of the 
freedom to provide services. The sale of medicinal products and medical devices via 
internet, long-term care services provided in residential homes, and the allocation of, 
and access to, organs for the purpose of organ transplantation are excluded from the 
scope of the Directive.  
It should be noted that the Regulation on the coordination of social security systems has 
a larger material scope than the Directive. It covers all benefits in kind, including those 
for long-term care, which are explicitly excluded from the scope of the Directive.  
Article 3(a) of the Directive defines healthcare as:  
‘healthcare’ means health services provided by health professionals to 
patients to assess, maintain or restore their state of health, including the 
prescription, dispensation and provision of medicinal products and medical 
devices 
This definition of healthcare is rather restrictive and appears to only apply to curative 
healthcare. That is, healthcare that is intended to improve symptoms and cure medical 
problems. The reason for excluding long-term care from the scope of the Directive is 
the complicity of the care, and the fact that the Member States provide and fund that 
care by different means.98  
The fourth paragraph of Article 1 expressly states that the Directive shall not affect laws 
and regulations in the Member States relating to the organisation and financing of 
healthcare in situations not related to cross-border healthcare. It is therefore clear that 
the Member States are intended to retain their powers to regulate in that area, and to 
build up and finance the national healthcare systems without intervention by the EU 
based on the Directive.  
The persons covered by the Directive are all those insured by the national social 
security systems of the Member States. Thus, the persons insured are the same as those 
insured under the social security coordination Regulation. Reimbursement of medical 
expenses obtained abroad is therefore based on the person being insured in the social 
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security system of the home State (the Directive uses the words “state of affiliation” for 
the Member State of residence, that is, the competent Member State to grant prior 
authorization to an insured person. To avoid complications “home State” will be used in 
this dissertation). The patients that might benefit from the Directive may have different 
reasons to seek healthcare abroad, such as temporary visitors abroad, people retiring to 
other countries, people living in border regions, people sent abroad by their home 
systems and people going abroad on their own initiative.   
 
4.2 The content of the Directive 
The adoption of the Directive was a big step in codifying the case law of the Court of 
Justice in the area of healthcare services, and much needed clarity about the rights of 
patients who seek healthcare in another Member State has hopefully been provided. The 
Directive is intended to supplement the rights that patients already have at EU level 
through the Regulation on the coordination of social security systems 883/2004 and 
clarify the relationship between the Regulation and the case law of the Court. At the 
same time the Directive shall fully respect the case law of the Court of Justice on cross-
border healthcare, as well as the right and competence of the Member States to organise 
their own healthcare system.99 The Directive does not affect the right of the Member 
States to define the benefits made available for their citizens, and the payment for the 
treatment sought abroad is therefore dependent on it also being funded when provided 
locally. While interpreting the rules set out in the Directive it is, first of all, important to 
keep in mind that the Directive speaks the voice of the patients. It is the rights of the 
patients that the Directive is intended to clarify.100 
The Directive sets out, as a general principle, that patients are allowed to obtain the 
same care as they would be entitled to at home, in another EU Member State, and have 
the costs reimbursed by the home State. The reimbursement is therefore dependent on 
the care sought being a part of the benefits basket of the Member State where the person 
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is insured. Thus, the healthcare available to patients is based on the decision of the 
national authorities of the home State. The Member States are, however, allowed to 
limit the application of this rule based on overriding reasons of general interest, such as 
planning requirements or the wish to control costs and avoid waste of financial, 
technical and human resources.  
Under specific conditions, such as with hospital and highly specialised care, the 
Member States may create a system of prior authorization, to limit the application of the 
rules of reimbursement. The Member States’ restriction of the free movement of 
healthcare services shall, however, be limited to what is necessary and proportionate to 
the objective to be achieved. In chapter 5, the rule on the right to reimbursement and 
prior authorization will be discussed further.  
While the healthcare that is sought cross-borders itself is mainly governed by the rules 
of the Member State where the treatment is sought, the reimbursement for the care is 
determined by the legislation of the Member State where the person is insured. The 
person seeking treatment under the conditions created by the Directive is only entitled 
to reimbursement up to the level that the same or similar treatment would have cost, had 
the treatment been provided at home. Consequently, the patient could end up paying 
some proportion of the expenses out of her own pocket. In the case of treatment costing 
less in the Member State of treatment, the level of reimbursement shall not exceed the 
actual amount paid for the healthcare. The patient cannot, therefore, gain any financial 
advantage by being treated abroad.  
The Directive works side by side with the social security coordination Regulation. 
When a patient applies for reimbursement the reimbursement shall be made according 
to the more beneficial system. This will generally be the coordination Regulation, when 
the conditions to benefits under that Regulation are met, as it provides for 
reimbursement at the tariff of the State of treatment.  
Finally, the Directive has some new rules that aim at promoting cooperation and mutual 
assistance in healthcare between the Member States. In order to improve transparency, 
national contact points for cross-border healthcare shall be set up. The contact points’ 
responsibilities shall, e.g. include to provide patients with information on the available 
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healthcare in its territory, e.g. about price, providers and redress procedures. Providing 
the relevant information to patients requesting them is regarded as a key issue for 
enabling cross-border healthcare. The national contact points shall also facilitate the 
exchange of information and cooperate with each other and the Commission. The 
Member State of treatment shall also ensure that the relevant healthcare providers 
provide sufficient information to patients to help them make an informed choice on 
treatment. If the healthcare providers already provide patients residing in the Member 
State of treatment with the information, the Directive does not oblige them to provide 
possible cross-border patients with more extensive information.   
Cooperation in eHealth and technology assessment shall also be increased, as well as 
the creation of a European Reference Network. The reference network shall be between 
the healthcare providers and centres of expertise in the Member States and have a 
special focus on rare diseases.  
The Directive also has a provision on mutual recognition of prescriptions issued in 
another Member State. In principle, if a medicinal product is authorized to be marketed 
on the territory of a Member State, that Member State shall ensure that prescriptions 
issued for such a product in another Member State, by a member of a regulated health 
profession within the meaning of Directive 2005/36, can be dispensed on their territory 
in compliance with their national legislation in force. However, a pharmacist still 
retains the right to refuse to dispense the prescription, according to national rules or for 
ethical reasons, when he would also have had that right had the prescription been issued 
in the Member State of affiliation.  
 
4.3 The relationship between the Directive and the social security coordination 
Regulation 
Before looking further at the right to reimbursement under the Directive it is necessary 
to consider the social security coordination Regulation, and the relationship between the 
two.  
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When the Directive comes into force, the social security coordination Regulation will 
still remain in place. The twofold route of authorization/reimbursement for cross-border 
healthcare services created by the Court rulings, one based on the rules of the 
Regulation and the other based on case law from the Court under Article 56 of the 
Treaty, will still exist. The rules of the Directive will, however, replace the latter route.   
In the Commission’s memorandum following the proposal for the Directive101 the 
Commission defines two main reasons why patients might prefer to get healthcare 
abroad: 
– the healthcare that they need is not available in their own system, or at least, not 
available within a reasonable time; or 
– the healthcare is available at home, but it is more convenient for them to have it 
abroad because it is closer, quicker, or better. 
The Commission considers those reasons different, where one is a matter of need and 
the other a personal preference, and finds there to be reasons to treat those groups of 
patients differently. If individuals need to seek healthcare abroad because the necessary 
care is not available domestically they should not suffer a financial loss by doing so. If, 
on the other hand, a person simply prefers to be treated abroad, the public funds should 
not have to pay the additional costs resulting from that choice. The reimbursement rules 
of the Directive follow this distinction by referring to the reimbursement rules of the 
social security coordination Regulation where relevant. The patients will, therefore, not 
be deprived of the more beneficial rights guaranteed under the Regulation because of 
the Directive.102   
In the case of emergency care, the rules of the Regulation should always be applied 
unless the patient specially requests otherwise. The rules of the Regulation are usually 
more beneficial to the patient, as the competent institutions in the relevant Member 
States shall make arrangements for the settlement of the costs. The patient receiving 
emergency care will then pay for the treatment as if he was insured in the State where 
the relevant treatment is given. Under the Directive the patient would generally have to 
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pay the whole amount up front, and later be reimbursed by the home State up to the 
level that the treatment would have cost if it had been provided at home. Patients in this 
position will, however, still benefit from the Directive as it contains requirements on 
providing them with information.  
Reimbursement rules for planned care in another Member State, which requires 
authorization, do also differ between the two legal measures. The rule in Article 20 of 
the coordination Regulation requires the patient to seek prior authorization from the 
competent institution. The authorization shall be provided if appropriate treatment 
cannot be given at home within a medically justifiable time limit, taking into account 
the current state of health and the probable course of the illness. The main rule of the 
Directive, on the other hand, is that the patient does not need to seek prior authorization. 
This rule of the Directive has several exceptions that will be discussed in the following 
chapter. Article 8(3) of the Directive states that if an insured person request prior 
authorization to seek cross-border care, the authorities shall, as a first step, determine 
whether the conditions for the application of the social security coordination 
Regulations have been met. Where the conditions have been met, i.e. the treatment 
cannot be provided at home without undue delay, the authorization shall be granted 
according to the Regulation unless the patient requests otherwise.  
By making it clear in the Directive that the social security Regulation shall have 
priority, the Directive guarantees patients the most beneficial reimbursement available. 
The difference in the cost of treatment in the home and host State will be paid by the 
patient if the authorization is provided under the rules of the Directive. Whereas, the 
authorization is granted under the Regulation, the difference will be covered by public 
funds. Reimbursement under the Regulation, therefore, ensures more financial security 
for the patient. The rules of the Regulation will not change following the 
implementation of the Directive.  
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5 Reimbursement under the Directive 
5.1 The general rule for reimbursement 
The general principle for reimbursement of medical expenses is established in Article 7 
of the Directive. It states that without prejudice to Regulation 883/2004 and subject to 
Articles 8 and 9 the home State shall ensure that costs incurred by an insured person 
who receives cross-border healthcare are reimbursed. This is limited to healthcare 
which the insured person is entitled to under the legislation of the home State. Excluded 
is therefore experimental treatment abroad, such as was at issue in the cases of Smits-
Peerboms and Rindal and Slinning, if there are no entitlements to such treatment in the 
home State. The Directive does therefore not provide for a general system of prior 
authorization as the social security Regulation. The Directive follows the Court rulings, 
where the Court has ruled that prior authorizations rules do in principle hinder the 
freedom to provide and receive services.103 The main rule is, therefore, that patients are 
in principle free to go to another Member State and get the healthcare they need, and 
have the costs reimbursed by the home State, given that the treatment sought is included 
in the benefits basket of their home State.  
The Directive therefore takes the opposite starting point to the social security 
Regulation. The main rule of the Regulation is that there is no entitlement to 
reimbursement for medical expenses obtained in another Member State, unless prior 
authorization has been received.  
Paragraph 9 of Article 7 of the Directive provides for a general exception from 
reimbursement of medical expenses obtained in another Member State. The rule 
stipulates that the Member States may limit the application of the rules on 
reimbursement for cross-border healthcare based on overriding reasons of general 
interest. These reasons can be, for example, planning requirements relating to the aim of 
ensuring sufficient and permanent access to a balanced range of high-quality treatment 
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in the State concerned, or the wish to control costs and avoid, as far as possible, any 
waste of financial, technical and human resources. Restrictions that are based on these 
grounds shall not go further than what is necessary and proportionate, and may not 
constitute a means of arbitrary discrimination or an unjustified obstacle to the free 
movement of goods, persons or services. If a Member States chooses to limit 
reimbursement on these grounds they shall notify the Commission of such decisions.  
This is an important exception from the main rule, and is a codification of principles 
established by the Court of Justice in several rulings that have already been discussed in 
chapter 3.1.1. In practice this possibility to limit the application of the main rule will 
likely be used by most of the Member States in order to protect the national healthcare 
services. 
 
5.2 The requirement of prior authorization 
The principal rule of the Directive, that medical expenses obtained in another EU 
Member State shall be reimbursed by the home State, can be further limited by the 
Member States. Article 8 of the Directive includes a special exception that allows the 
Member States to introduce a system of prior authorization for reimbursement of 
medical expenses. The requirement of prior authorization is seen by the Commission 
and the Court as hindering free movement of services, as was explained in chapters 3.1 
and 3.2.104 The Court has, however, held that restricting the reimbursement for 
healthcare obtained abroad can be justified on the ground of overriding reasons in the 
general interest, and that a prior authorization system can therefore be compatible with 
the Treaty. The system of prior authorization and the decision to turn down a request for 
prior authorization shall be restricted to what is necessary and proportionate to the 
objective to be achieved. It may, furthermore, not constitute a means of arbitrary 
discrimination or an unjustified obstacle to the free movement of patients.  
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The requirement of prior authorization is according to Article 8(2) limited to healthcare 
in four instances that is:  
a)  made subject to planning requirements relating to the object of ensuring 
sufficient and permanent access to a balanced range of high-quality 
treatment in the Member State concerned or to the wish to control costs 
and avoid any waste of financial, technical and human resources and; 
i.  the healthcare sought must involve overnight hospital stay for at least 
one night or  
ii.  require use of highly specialized and cost-intensive medical 
infrastructure or medical equipment.  
b)  Healthcare that involves treatment presenting a particular risk for the 
patient or the population.  
c)  Healthcare that is provided by a healthcare provider that, on a case by 
case basis, could give rise to serious and specific concerns relating to the 
quality or safety of the care, with the exception of healthcare which is 
subject to Union legislation ensuring a minimum level of safety and quality 
throughout the Union. 
It is left to the Member States themselves to decide which categories of healthcare they 
will make subject to prior authorization. The categories of healthcare may therefore 
vary between each Member State, as the organization and delivery of healthcare is 
different between the Member States, and different criteria may be used for defining the 
healthcare where authorization is needed. The categories in point (a) that are made 
subject to prior authorization shall be notified to the Commission. The Member States 
shall make the healthcare that they make subject to prior authorization publicly 
available, as well as the relevant information on the prior authorization system. The 
Directive therefore follows closely the Court rulings on prior authorization, where the 
Court stated in Smits-Peerboms, that prior authorization could be accepted as long as it 
could be considered necessary and proportionate and it must be based on an objective 
and non-discriminatory criteria that is known in advance.105   
In the initial proposal for a Directive, the Commission intended to have these categories 
administered through a body by the Commission.106 The Parliament and the Council, 
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however, rejected the idea of a common definition for healthcare that may be subject to 
prior authorization as they considered it preferable that this would be defined by the 
Member States themselves.107 This freedom of the Member States to decide which 
healthcare that needs prior authorization may lead to a broader list than was intended by 
the Commission. On the positive side, it is important with clarity about which 
healthcare that is subject to prior authorization, and what level of reimbursement a 
patient that intends to apply for authorization, or has received one, might be entitled to. 
The patient then knows what payments he might expect on his return home as well as 
he can organize appointments for after-treatment. 
 
5.2.1 Hospital treatment 
Like the Court has previously done in its rulings, the Directive makes a distinction 
between hospital care and care provided outside of a hospital, and thereby recognizes 
the specific nature of hospital services.108 As provided for in Article 8(2), healthcare 
that is made subject to planning and involves overnight hospital accommodation for at 
least one night may be subject to prior authorization. The Article thereby sets out in a 
clear way what constitutes hospital care as it depends on the overnight stay. Thus, if a 
person seeks healthcare in another Member State and attends a follow up on the 
following day after spending the night at a hotel or with relatives, it is not considered 
hospital care as the night is not spent at the hospital.  
Prior to the Directive there has been no consistent definition in the different health 
systems in the EU of what constitutes hospital care. This definition therefore provides 
for a minimum harmonization between the various healthcare systems, and therefore 
gives more clarity to the patients considering healthcare abroad.109  
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The Member States may justify the prior authorization system for hospital care by the 
need to plan the number of hospitals, their geographic distribution, the mode of their 
organization and the equipment with which they are provided. Such planning seeks to 
achieve the aim of ensuring sufficient and permanent access to a balance range of high-
quality hospital treatment in the State concerned. It also assists in meeting a desire to 
control costs and to prevent, as far as possible, any wastage of financial, technical and 
human resources.110 Requiring prior authorization for hospital care therefore appears to 
be a measure that is both necessary and reasonable.111  
If a Member State chooses to use this possibility to limit the reimbursement for hospital 
treatment provided in another Member State, the rule does not require the national 
authorities to demonstrate how this limitation is necessary to prevent distortion of the 
national system. It remains to be seen how this will work in practice and the Member 
State should, when making hospital care subject to prior authorization, use the previous 
rulings of the Court of Justice as an advice.       
 
5.2.2 Highly specialized treatment 
The Directive also allows the Member States to make subject to prior authorization 
healthcare that is not provided in a hospital, but is made subject to planning 
requirements and “requires use of highly specialized and cost-intensive medical 
infrastructure or medical equipment”. It is not clear what equipment or infrastructure 
the Directive is referring to, and one must therefore rely on previous interpretations by 
the Court.  
In paragraphs 40 and 41 in the preamble to the Directive it is stated that it is for each 
Member State to decide whether a treatment is subject to prior authorization. Whether 
or not prior authorization for the treatment will be permitted will vary and will depend 
on the type of equipment. Whether the healthcare is delivered in or out of hospital 
environment is not the decisive factor for deciding whether it requires planning or not. 
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As Advocate General Sharpston suggested in her Opinion112 in the case Commission v 
France, there are several factors to take into consideration when evaluating the 
legitimacy of a national rule requiring prior authorization for treatment that is highly 
specialized or cost-intensive. First, whether the capital cost of the equipment in question 
is high, and if the cost is likely to be very considerable and require a substantial 
investment by the competent authorities. Secondly, the operating costs may be 
sufficiently significant to require separate provision within the relevant budget. Third, 
the equipment in question will probably be specialist equipment, in the sense of the 
equipment that is dedicated to a particular medical procedure or type of analysis. 
Fourth, it is likely to be equipment that is used only after the patient has been through 
some kind of preliminary screening process, rather than equipment that is used routinely 
for first stage diagnosis and/or treatment. Fifth, the equipment may well require 
suitably-trained staff to install, maintain and operate it. 
This point is open for interpretations by the Member States, and each Member State 
might interpret it differently. Future disputes before the Courts regarding the 
understanding of this point are therefore expected, as the Member States might be 
inclined to conclude “a bit to easily”113 that a specific treatment needs expensive 
equipment that will need planning, and therefore consider the requirement of the 
Directive, to require prior authorization, fulfilled.   
5.2.3 Particular risk for the patient or for the population 
If the healthcare involves treatments presenting a particular risk for the patient or the 
population it may be made subject to prior authorization. This rule must be considered 
to exist in order for the authorities to protect the citizens against specific concerns.  
One can imagine patients wishing to travel with highly infectious diseases for example, 
or patients that have highly unstable conditions that might not allow them to safely 
make long distance journeys. The authorization might also, possibly, be turned down on 
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the grounds that the patient is wishing to travel to a Member State at a time when an 
infectious disease is occurring there.  
 
5.2.4 Concerns about the healthcare provider 
Healthcare may be subject to prior authorization if it is provided by a healthcare 
provider that could give rise to serious and specific concerns relating to the quality or 
safety of the care. This does not, however, apply to healthcare which is subject to Union 
legislation ensuring a minimum level of safety and quality throughout the union.  
The Court stated in its ruling in Kohll, that the Luxembourg authorities could not argue 
that the prior authorization was necessary in order to ensure the safety and quality of the 
treatment, as the activities of health professionals had been subject to EU harmonization 
Directives.114 For this reason it is not clear when this point could be used to require 
prior authorization. See further chapter 5.3 below on Article 8(6)(c).   
 
5.3 Reasons to refuse to provide prior authorization and the concept of 
“undue delay” 
The Member States have limited reasons to refuse to grant prior authorization, 
following the exhaustive list in Article 8(6) of the Directive. As the social security 
Regulation did not include any rules on when authorization could be refused, 
these rules are new. The list is limited, which is perhaps appropriate given the 
broad scope of healthcare that may be subject to prior authorization and that the 
Member States already have the right to limit the reimbursement based on 
overriding reasons of general interest, as discussed above in chapter 5.1.   
According to point (a) of paragraph 6, application for authorization to seek cross-border 
healthcare may be refused, if a clinical evaluation of the treatment has been made, and 
that evaluation indicates, that the patient will with reasonable certainty be exposed to a 
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patient-safety risk. This risk must be deemed not acceptable, taking into account the 
potential benefit the patient might gain from the treatment. 
Following point (b) the authorization may furthermore be refused, if the cross-border 
healthcare will, with reasonable certainty, result in exposing the general public to a 
substantial safety hazard.  
Point (c) relates to chapter 5.2.4 above, and states that the authorization can be turned 
down if the healthcare is to be provided by a healthcare provider that raises specific 
concerns that relate to the quality of care and patient safety. As stated in chapter 5.2.4, it 
is not clear when the Member States can use this reason to refuse to provide prior 
authorization. It must be assumed, however, that the Member State raising this 
justification has concrete concerns relating to the compliance with the applicable quality 
and safety standards of the care in the EU.   
Point (d) states that the prior authorization can be refused if the healthcare can be 
provided on the territory of the home State within a time limit which is medically 
justifiable. The authorities must take into account the patients current state of health and 
the probable course of the illness. This reason to refuse prior authorization is likely to 
be much used by the national authorities.  
The Member States cannot, however, refuse to grant prior authorization when the 
healthcare cannot be provided by a nationally based provider within undue delay. This 
rule is set out in further detail in paragraph 5 of Article 8.  
The concept of “undue delay” has been the subject of many rulings from the Court of 
justice. Although the Member States are free, within the limits laid down in Article 8 of 
the Directive, to define the scope of healthcare that requires authorization, the Court has 
repeatedly ruled that authorization cannot be refused when the patient is entitled to the 
healthcare in question in accordance with national law, and the healthcare cannot be 
obtained at home within medically justifiable time limits.115 In paragraph 5 of Article 8 
it is stated, that the Member States cannot refuse to grant prior authorization when 
healthcare cannot be provided within a time limit which is medically justifiable. It 
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further states, that when evaluating the need for a treatment, the competent institution is 
required to base the decision on an objective medical assessment of the patients’ 
medical condition, the history and probable course of the patients’ illness, the degree of 
the patients’ pain and/or the nature of the patients’ disability at the time when the 
request for authorization was made.  
The description of “undue delay” in the Directive is more detailed than it is set out in 
Article 20(2) of the coordination Regulation. There it is merely stated that authorization 
shall be given where the treatment in question is among the benefits provided for by the 
legislation in the Member State where the person concerned resides, and where the 
treatment cannot be given within a time limit which is medically justifiable taking into 
account the patients current state of health and probable course of the illness.  
The national authorities are entitled to use waiting lists to manage available hospital 
capacity and to prioritize in their territory. The Court has, however, made clear that the 
existence of waiting lists for hospital treatment in itself does not justify a refusal to 
provide authorization to seek necessary treatment abroad. The competent institution to 
grant prior authorization is required to take into account all circumstances of the 
individual case and the clinical needs of the person.116 
In the case of Mûller-Faure the Court found that when determining whether treatment 
which is equally effective can be obtained without undue delay, all circumstances of 
each specific case shall be considered. Account shall be taken of the patients’ medical 
condition at the time when authorization is sought and medical history. Furthermore, 
the degree of pain shall be considered or the nature of the disability which might, for 
example, make it impossible or extremely difficult for him to carry out a professional 
activity.117 
To conclude, when the patient is entitled to healthcare at home that cannot be provided 
within a medically justifiable time limit, the State is in principle obliged to grant prior 
authorization. In certain circumstances defined in Article 8(6), cross-border healthcare 
may expose the patient or the general public to a risk which overrides the interest of the 
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patient to receive the cross-border healthcare sought. The granting of prior authorization 
can also be restricted based on concerns relating to the healthcare provider. In such 
instances, the home State should have the opportunity to refuse the request for prior 
authorization, and direct the patient towards alternative solutions. 
 
5.4 Summarizing the rule on the right to reimbursement 
The Directive sets out the main rule that patients are in principle free to get the medical 
care they are entitled to at home in another EU State, and get the costs reimbursed by 
their home State. There are, however, many exceptions to this rule, which in effect 
significantly impedes the main rule.   
The general exception from this rule is that the reimbursement can be limited based on 
overriding reasons of general interest. This is a broad restriction on the free movement 
of services, which is based on the Court rulings in several cases where the Court has 
found such measures to be both necessary and proportionate. Furthermore, the Member 
States may limit the application of the rules on reimbursement even further by 
introducing a system of prior authorization. The prior authorization may be refused if 
the treatment can be provided at home within a medically justifiable time limit, but 
may, however, not be refused if it cannot be provided at home without undue delay for 
the patient. However, if the reasons listed in the exhaustive list in Article 8(6) (a) – (c) 
are applicable, they may in turn override the obligation of the Member States to provide 
treatment without undue delay. 
It is most likely that all the Member States will use the opportunity and limit the right to 
seek healthcare cross borders based on the reasons of general interest. It must also be 
considered likely that they will introduce a system of prior authorization. The system 
will vary between each Member State, as the States organize their healthcare systems 
differently, as well as having different financial means.  
Following the Directive reimbursement is only made up to the level that the treatment 
would have cost had it been provided in the home State. This has, however, been 
criticized in the light of the principle of equal treatment and the free movement of 
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persons. As the patient has to pay the difference between the actual cost of treatment 
and the reimbursement received, patient mobility can be restricted. The Directive will 
therefore likely primarily be used to seek reimbursement for treatment abroad that is 
provided at similar or lower costs as in the patients’ home State.118   
 
5.5 Administrative procedures 
The administrative procedures regarding cross-border healthcare are mostly laid down 
in Articles 7 and 9 of the Directive. The procedures will not all be listed here, but those 
relevant for the topic of this dissertation will be addressed.  
The Member States shall set out reasonable time limits to deal with requests for cross-
border healthcare and make them public in advance. In the initial proposal the 
Commission considered a period of fifteen calendar days considered normal, and this 
could be shorter if urgency requires.119 The administrative procedures shall be based on 
objective, non-discriminatory criteria and the criteria shall be necessary and 
proportionate to the objective to be achieved. When the competent authorities in the 
Member States are considering a request for cross-border healthcare, they shall take into 
account (i) the patient’s specific medical condition and (ii) the urgency and other 
individual circumstances. The decisions following a request for cross-border healthcare 
shall be properly reasoned and be subject to judicial review. 
As previously mentioned, after receiving a request for prior authorization to seek 
treatment abroad, the first step is to determine whether the conditions laid down in 
Regulation 883/2004 have been met. Where those conditions are met, the prior 
authorization shall be granted according to the Regulation unless the patient requests 
otherwise.  
When a patient is seeking reimbursement for cross-border healthcare, the home State 
may, according to Article 7(7), impose on the person the same requirements as it would 
if the treatment had been provided at home. This has been referred to as the “gate-
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keeping-principle”. This can consist of an assessment by a health professional or 
healthcare administrator providing services for the health system of the State where the 
person is insured. This may e.g. include an obligation to consult a general practitioner 
before consulting a specialist, or before receiving hospital treatment.  
As the State where the healthcare is given treats the patient according to its own 
legislation this must be considered to apply also to the State of treatment. The Member 
States can therefore set this as a condition for accepting patients from other EU States. 
The Member States may only require this if necessary for determining the individual 
patient’s entitlements to healthcare. Patients seeking cross-border healthcare may not be 
subject to any additional conditions that do not apply when the treatment is provided by 
a nationally based provider.  
The competent institution of the home State shall reimburse the costs to the patient, or 
directly to the institution in the place where the treatment was given. The amount shall 
be made up to the level of the costs that the same or similar healthcare would have cost 
had it been provided at home and shall not exceed the actual cost of the healthcare 
received. The Member State may decide to reimburse other related costs, such as 
accommodation and travel costs, or extra costs which persons with disabilities might 
incur due to one or more disabilities when receiving cross-border healthcare. These 
costs will be reimbursed in accordance with national legislation and on the condition 
that there is sufficient documentation setting out the costs.   
The Member States shall, according to Article 7(6), set up a transparent mechanism for 
cost calculation. The mechanism shall be based on objective, non-discriminatory 
criteria known in advance and applied at the relevant administrative level. This 
obligation may be related to the problem in the Watts case, where the Court had to rule 
on how to determine the reimbursement rate to Ms Watts. The Court of justice has 
developed an approach based on the presumption that the patient must be placed in the 
position he would have been in had he undergone the operation at home. As the British 
NHS system, where Ms Watts was insured, provided the treatment free of charge, the 
State was forced to carry out a comparative analysis of the costs to determine on the 
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amount of reimbursement.120 This mechanism has also been criticized as it will be a 
complicated work for the Member States to define the costs for treatments and, 
secondly, the rule does not set out a measure that harmonizes the methodology used by 
the Member States for the cost calculation.121  
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6 Conclusion 
Having assessed the Court rulings regarding cross-border healthcare from Kohll and 
Decker and until today, it is clear that the involvement of the EU was necessary as the 
right to seek treatment cross-borders has been unclear. The Directive follows closely the 
case law from the Court, and sets out clarification on the rights of individuals to get the 
costs for cross-border healthcare reimbursed. Having assessed the rules of the Directive, 
especially Articles 7 and 8, one can however ask whether the objective of the Directive, 
to provide legal clarity and certainty, really has been achieved, as the exceptions to 
reimbursement are quite cumbersome? 
The Directive sets out the principal rule discussed in chapter 5.1 above, that patients are 
free to seek healthcare in another EU Member State and get the costs reimbursed by the 
home state. It is, however, only the cost of healthcare that the patients already have 
right to under their national healthcare system that is to be reimbursed. The Member 
States may, furthermore, limit this freedom based on overriding reasons of general 
interest, such as planning requirements relating to the aim of ensuring sufficient and 
permanent access to a balanced range of high-quality treatment in the State concerned, 
or the wish to control costs and avoid, as far as possible, any waste of financial, 
technical and human resources. Article 8 allows for further limitation by giving the 
Member States the opportunity to introduce a system of prior authorization.  
The rules of the social security Regulation will still remain in place. The authorization 
procedure in the Regulation is different to that of the Directive. The fact that the two 
legal tools do not have completely identical procedures can make it more difficult for 
insured persons to understand their rights to seek healthcare in another EU State.  
With those two legal tools working side by side the parallel route to reimbursement 
created by the Court rulings on Article 56 continues to remain. When the conditions for 
reimbursement under the social security Regulation are met, the reimbursement shall be 
made under that Regulation. Under the Regulation the patient pays for the healthcare 
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received abroad as if he was insured under that system, while the home State reimburses 
the cost to the institution in the place where he was treated. Under the Directive, on the 
other hand, the patient pays the full amount for the treatment, and is then entitled to be 
reimbursed by the home State up to the amount that the treatment would have cost had 
it been provided at by a nationally based provider.   
To enhance clarity and avoid complications between the Directive and the Regulation, 
including the principles of the Court’s rulings in the social security Regulation, instead 
of giving a new Directive, could have been a better way forward.  
Following the adoption of the Directive, some have worried that the EU is reaching to 
far by regulating the healthcare market and that the sovereignty of the national 
healthcare systems is at risk. The Directive does, however, clearly state that it is not 
intended to affect the national organization of healthcare services and it appears as the 
Directive will not increase the right to treatment in any way.  
To conclude, it is safe to say that the Directive has given some clarification and 
practical effect to the rights that the Court recognized in its rulings. The right to seek 
healthcare in another Member State, and have the costs reimbursed from the home 
State, is a right that many EU nationals have not been aware of. The entering into force 
of the Directive is likely to increase awareness of the possibility to seek healthcare 
abroad and get the costs reimbursed. More EU nationals are therefore likely to use their 
right to seek healthcare cross borders in the coming years.  
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